The DOI matches its Crossref record; 149 of the 150 references it cites were found in a registry or an index.
The molecular bases of Alzheimer’s disease and other neurodegenerative disorders
Open accessAbstract
Alzheimer's disease, the cause of one of the most common types of dementia, is a brain disorder affecting the elderly and is characterized by the formation of two main protein aggregates: senile plaques and neurofibrillary tangles, which are involved in the process leading to progressive neuronal degeneration and death. Neurodegeneration in Alzheimer's disease is a pathologic condition of cells rather than an accelerated way of aging. The senile plaques are generated by a deposition in the human brain of fibrils of the beta-amyloid peptide (Abeta), a fragment derived from the proteolytic processing of the amyloid precursor protein (APP). Tau protein is the major component of paired helical filaments (PHFs), which form a compact filamentous network described as neurofibrillary tangles (NFTs). Experiments with hippocampal cells in culture have indicated a relationship between fibrillary amyloid and the cascade of molecular signals that trigger tau hyperphosphorylations. Two main protein kinases have been shown to be involved in anomalous tau phosphorylations: the cyclin-dependent kinase Cdk5 and glycogen synthase kinase GSK3beta. Cdk5 plays a critical role in brain development and is associated with neurogenesis as revealed by studies in brain cells in culture and neuroblastoma cells. Deregulation of this protein kinase as induced by extracellular amyloid loading results in tau hyperphosphorylations, thus triggering a sequence of molecular events that lead to neuronal degeneration. Inhibitors of Cdk5 and GSK3beta and antisense oligonucleotides exert protection against neuronal death. On the other hand, there is cumulative evidence from studies in cultured brain cells and on brains that oxidative stress constitutes a main factor in the modification of normal signaling pathways in neuronal cells, leading to biochemical and structural abnormalities and neurodegeneration as related to the pathogenesis of Alzheimer's disease. This review is focused on the main protein aggregates responsible for neuronal death in both sporadic and familial forms of Alzheimer's disease, as well as on the alterations in the normal signaling pathways of functional neurons directly involved in neurodegeneration. The analysis is extended to the action of neuroprotective factors including selective inhibitors of tau phosphorylating protein kinases, estrogens, and antioxidants among other molecules that apparently prevent neuronal degeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NTFs contain, as their first component, aggregates of the protein tau (τ) in a hyperphosphorylated state.”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [19]
In the citing paper
“in healthy neuronal cells, following consecutive and reversible enzymatic processes of phosphorylation and dephosphorylation, it has the task of assembling and stabilizing microtubules and determining their binding with other components of the cytoskeleton [19,20].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [19]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy‐Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,715
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
Research works printed but not linked: 2
- Catania, 2001, Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells, Neurooncology, 3, 89
- Saez, 1990, Gap junctions, In Vitro Toxicol, 3, 69
Cited by
Sorted by citations
Items 201–300 of 477
Jia, Z., Misra, B. R., Zhu, H., Li, Y., & Misra, H. P. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.11.007 · Cited by 38
HIV-1 Nef in Macrophage-Mediated Disease Pathogenesis
Lamers, S. L., Fogel, G. B., Singer, E. J., Salemi, M., Nolan, D. J., Huysentruyt, L. C., & McGrath, M. S. (2012) · International Reviews of Immunology · doi:10.3109/08830185.2012.737073 · Cited by 37
Liu, H.-Y., & Pfleger, C. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0032835 · Cited by 37
Dedov, V. N., Dedova, I. V., Merrill, A. H., & Nicholson, G. A. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.12.005 · Cited by 37
Cognitive impairment and Alzheimer’s disease: Links with oxidative stress and cholesterol metabolism
Maccioni, R. B. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3268 · Cited by 36
Protective Effect of Ginger (Zingiber officinale) on Alzheimer's disease Induced in Rats
Mahdy, K. A., Gouda, N. A., Marrie, A. E.-F. H., Yassin, N., El-Shenawy, S. M. A., Farrag, A. R. H., & Ibrahim, B. M. M. (2014) · Journal of Neuroinfectious Diseases · doi:10.4172/2314-7326.1000159 · Cited by 36
Herrup, K. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e527 · Cited by 36
Herrup, K. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/527 · Cited by 35
Jang, S. I., Pae, H., Choi, B., Oh, G., Jeong, S.-I., Lee, H. J., Kim, H. Y., Kang, K. J., Yun, Y. G., Kim, Y. C., et al. (2003) · Immunopharmacology and Immunotoxicology · doi:10.1081/iph-120024498 · Cited by 35
Natural antioxidants in prevention and management of Alzheimer's disease
Zhao, Y. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/419 · Cited by 35
Stevanović, I. D., Jovanović, M., Čolić, M. J., Jelenković, A., Bokonjić, D., & Ninković, M. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.01.004 · Cited by 34
Lin, K., Chen, S., Lai, L., Huang, Y., Chen, J., Chen, T., Sun, Y., Wen, L., Yip, P., Chu, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020573 · Cited by 32
Wang, Y., Feng, Y., FU, Q., & Li, L. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1215 · Cited by 33
Sp3 and Sp4 Transcription Factor Levels Are Increased in Brains of Patients with Alzheimer’s Disease
Boutillier, S., Lannes, B., Buée, L., Delacourte, A., Rouaux, C., Mohr, M., Bellocq, J., Sellal, F., Larmet, Y., Boutillier, A., et al. (2007) · Neurodegenerative Diseases · doi:10.1159/000107701 · Cited by 33
Tao, R., Lu, Z., Ding, D., Fu, S., Hong, Z., Liang, X., Zheng, L., Xiao, Y., & Zhao, Q. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.04.003 · Cited by 32
TrkA pathway activation induced by amyloid-beta (Abeta)
Bulbarelli, A., Lonati, E., Cazzaniga, E., Re, F., Sesana, S., Barisani, D., Sancini, G., Mutoh, T., & Masserini, M. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.12.006 · Cited by 32
Jia, Z., Zhu, H., Li, Y., & Misra, H. P. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9978-8 · Cited by 32
Kulshreshtha, A., & Piplani, P. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.06.046 · Cited by 33
Protein Aggregation in Alzheimers Disease and Other Neoropathological Disorders
Dimakopoulos, A. C. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772795 · Cited by 33
Oxidative Stress and Alzheimer’s Disease
Singh, S. K., Castellani, R. J., & Perry, G. L. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-33486-8_10 · Cited by 33
Kantar, D., Öztürk, N., Er, H., Aslan, M., Demır, N., Derin, N., Ağar, A., & Yargıçoğlu, P. (2015) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2015.0034 · Cited by 32
Action of estrogen on survival of basal forebrain cholinergic neurons: Promoting amelioration
Ábrahám, I. M., Kőszegi, Z., Tolod-Kemp, E., & Szegő, É. M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.024 · Cited by 31
Anand, S., Barnes, J. M., Young, S. A., García, D. M., Tolley, H. D., Kauwe, J. S. K., & Graves, S. W. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170035 · Cited by 31
Effects of treadmill exercise on PI3K/AKT/GSK-3β pathway and tau protein in high-fat diet-fed rats
Jeong, J., & Kang, E. (2018) · Physical Activity and Nutrition · doi:10.20463/jenb.2018.0002 · Cited by 31
ApoE Alleles and Tau Markers in Patients with Different Levels of Cognitive Impairment
Manuel Lavados, M., Farias, G. A., Rothhammer, F., Guillón, M., Mujica, M. V., Maccioni, C., & Maccioni, R. B. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.03.036 · Cited by 32
When Sporadic Disease Is Not Sporadic
Goldman, J. S., Miller, B. L., Safar, J., de Tourreil, S., Martindale, J. L., Prusiner, S. B., & Geschwind, M. D. (2004) · Archives of Neurology · doi:10.1001/archneur.61.2.213 · Cited by 31
Neurodegenerative conditions associated with ageing: a molecular interplay?
Troulinaki, K., & Tavernarakis, N. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.09.033 · Cited by 31
Verdaguer, E., Alvira, D., Jiménez, A., Rimbau, V., Camins, A., & Pallàs, M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706280 · Cited by 30
Geldanamycin Reduces Aβ-Associated Anxiety and Depression, Concurrent with Autophagy Provocation
Zare, N., Khalifeh, S., Khodagholi, F., Shahamati, S. Z., Motamedi, F., & Maghsoudi, N. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0619-1 · Cited by 30
Kumar, S. E. P., Bairy, L. K., Nayak, V., Reddy, S. K., Kiran, A., & Abhijna Ballal, R. (2019) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1692 · Cited by 29
Cook, R., Lu, L., Gu, J., Williams, R. W., & Smeyne, R. J. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00659-9 · Cited by 28
Tau Oligomers in Sera of Patients with Alzheimer’s Disease and Aged Controls
Kolarova, M., Sengupta, U., Bartos, A., Ricny, J., & Kayed, R. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170048 · Cited by 27
Goubau, C., Buyse, G., Geet, C. V., & Freson, K. (2014) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12421 · Cited by 27
Nakamura, M., Yamada, M., Ohsawa, T., Morisawa, H., Nishine, T., Nishimura, O., & Toda, T. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.07.008 · Cited by 27
Neuroinflammation and Neurodegeneration
Morales, I., Farias, G. A., Cortés, N., & Maccioni, R. B. (2016) · InTech eBooks · doi:10.5772/64545 · Cited by 34
Patricio-Martínez, A., Sánchez‐Zavaleta, R., Angulo-Cruz, I., Gutierrez-Praxedis, L., Hernández, E. R., Martínez-García, I., & Limón, I. D. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.08.001 · Cited by 27
Rational design of potent GSK3β inhibitors with selectivity for Cdk1 and Cdk2
Lesuisse, D., Dutruc-Rosset, G., Tiraboschi, G., Dreyer, M., Maignan, S., Chevalier, A., Halley, F., Bertrand, P., Burgevin, M., Quarteronet, D., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.114 · Cited by 26
Wang, L., Lin, F., Wang, J., Wu, J., Han, R., Zhu, L., Zhang, G., DiFiglia, M., & Qin, Z. (2012) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr125 · Cited by 26
Methylene blue and its importance in medicine
Kayabaşı, Y. (2020) · Demiroglu Science University Florence Nightingale Journal of Medicine · doi:10.5606/fng.btd.2020.25035 · Cited by 27
New Drug Design Avenues Targeting Alzheimer’s Disease by Pharmacoinformatics-Aided Tools
Arrué, L., Cigna-Méndez, A., Barbosa, T., Borrego-Muñoz, P., Struve-Villalobos, S., Oviedo, V., Martínez-García, C., Sepúlveda-Lara, A., Millán, N., Montesinos, J. C. E. M., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091914 · Cited by 28
An overview of biomarkers in Alzheimer′s disease
Mathuranath, P. S., & Wattamwar, P. R. (2010) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.74256 · Cited by 28
González‐Domínguez, R., Sayago, A., & Fernández‐Recamales, Á. (2018) · Metabolites · doi:10.3390/metabo8030052 · Cited by 24
Trunova, S. A., & Giniger, E. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008847 · Cited by 24
Anukulthanakorn, K., Parhar, I. S., Jaroenporn, S., Kitahashi, T., Watanbe, G., & Malaivijitnond, S. (2016) · Phytotherapy Research · doi:10.1002/ptr.5595 · Cited by 25
Impaired Axonal Transport in Motor Neurons Correlates with Clinical Prion Disease
Ermolayev, V., Cathomen, T., Merk, J., Friedrich, M., Härtig, W., Harms, G. S., Klein, M. A., & Flechsig, E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000558 · Cited by 24
Estradiol prevents olfactory dysfunction induced by A-β 25–35 injection in hippocampus
Bernal-Mondragón, C., Rivas-Arancibia, S., Kendrick, K. M., & Guevara‐Guzmán, R. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-104 · Cited by 24
The sources of salidroside and its targeting for multiple chronic diseases
Xie, H. L., Shen, C., & Jiang, J. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103648 · Cited by 24
A shared comparison of diabetes mellitus and neurodegenerative disorders
Morsi, M., Kobeissy, F. H., Magdeldin, S., Maher, A., Aboelmagd, O., Johar, D., & Bernstein, L. H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28094 · Cited by 25
Neuronal Cell Cycle Re-Entry Markers are Altered in the Senescence Accelerated Mouse P8 (SAMP8)
Casadesús, G., Cuesta, J., Lee, H., Jiménez, A., Tajes, M., Ortuño‐Sahagún, D., Camins, A., Smith, M. A., & Pallàs, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120112 · Cited by 23
Dułak, D., Gadzała, M., Banach, M., Ptak, M., Wiśniowski, Z., Konieczny, L., & Roterman, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102910 · Cited by 22
Kaniaková, M., Nepovimová, E., Kletečková, L., Skřenková, K., Holubová, K., Chrienová, Ž., Hepnarová, V., Kucera, T., Kobrlová, T., Valeš, K., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190228122218 · Cited by 24
Wang, L., Zuo, B., Xu, D., Ren, Z., Zhang, H., Li, X., Lei, M., & Xiong, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040250 · Cited by 24
Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer’s Disease
Adiele, R. C., & Adiele, C. A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150967 · Cited by 23
Uddin, M. S., Kabir, M. T., Rahman, M. H., Alim, M. A., Rahman, M. M., Khatkar, A., Mamun, A. A., Rauf, A., Mathew, B., & Ashraf, G. M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200406075044 · Cited by 22
Emerging Noninvasive Biomarkers for Early Detection of Alzheimer's Disease
Guzmán‐Martínez, L., Farias, G. A., & Maccioni, R. B. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.013 · Cited by 23
Association between ABCB1 polymorphisms and haplotypes and Alzheimer’s disease: a meta-analysis
Zhong, X., Liu, M.-Y., Sun, X., & Wei, M. (2016) · Scientific Reports · doi:10.1038/srep32708 · Cited by 22
Farbood, Y., Shabani, S., Sarkaki, A., Mard, S. A., Ahangarpour, A., & Khorsandi, L. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-016-9947-2 · Cited by 22
., K., Yangqian, & Bais, S. (2018) · International Journal of Pharmacology · doi:10.3923/ijp.2018.879.888 · Cited by 22
Kelz, M. B., Dent, G. W., Therianos, S., Marciano, P. G., McIntosh, T. K., Coleman, P. D., & Eberwine, J. H. (2002) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2002.1.re1 · Cited by 22
Cardone, A., Hassan, S. A., Albers, R. W., Sriram, R. D., & Pant, H. C. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.06.040 · Cited by 21
Mitochondrial trafficking in neuropsychiatric diseases
Deheshi, S., Pasqualotto, B. A., & Rintoul, G. L. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.015 · Cited by 21
Patricio-Martínez, A., Patricio, F., Macuil-Chapuli, E., Martínez-Juárez, E. Á., Flores-Díaz, S., Cedillo-Ramirez, M. L., & Limón, I. D. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1598011 · Cited by 23
Zhang, L., Xu, M., Ren, Q., Liu, G., Meng, S., Xiahou, K., Zhang, Y., Jiang, N., & Zhou, W. (2020) · Stem Cells and Development · doi:10.1089/scd.2020.0103 · Cited by 20
Serum brain-derived neurotrophic factor, nerve growth factor and neurotrophin-3 levels in dementia
Konukoğlu, D., Andican, G., Fırtına, S., Erkol, G., & Kurt, A. (2012) · Acta Neurologica Belgica · doi:10.1007/s13760-012-0101-6 · Cited by 20
Shabani, S., Sarkaki, A., Mard, S. A., Ahangarpour, A., Khorsandi, L., & Farbood, Y. (2016) · Neuropeptides · doi:10.1016/j.npep.2016.09.003 · Cited by 20
Krüppel-like Factor 8 Ameliorates Alzheimer's Disease by Activating β-Catenin
Yi, R., Chen, B., Zhao, J., Zhan, X., Zhang, L., Liu, X.-M., & Dong, Q. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0131-4 · Cited by 20
Andrade, V., Cortés, N., Pastor, G., González, A., Ramos-Escobar, N., Pastene, E., Rojo, L. E., & Maccioni, R. B. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200067 · Cited by 19
Payrits, M., Borbély, É., Godó, S., Ernszt, D., Kemény, Á., Kardos, J., Szőke, É., & Pintér, E. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111268 · Cited by 18
Peripheral biomarkers of oxidative stress in aging and Alzheimer's disease
Marcourakis, T., Camarini, R., Kawamoto, E. M., Scorsi, L. R., & Scavone, C. (2008) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642009dn20100002 · Cited by 21
Apolipoprotein E genotype is related to nitric oxide production in platelets
Marcourakis, T., Bahia, V. S., Kawamoto, E. M., Munhoz, C. D., Gorjão, R., Artes, R., Kok, F., Caramelli, P., Nitríni, R., Curi, R., et al. (2008) · Cell Biochemistry and Function · doi:10.1002/cbf.1516 · Cited by 19
Calcium-dependent and aspartyl proteases in neurodegeneration and ageing in C. elegans
Samara, C., & Tavernarakis, N. (2003) · Ageing Research Reviews · doi:10.1016/s1568-1637(03)00032-1 · Cited by 19
Spontaneous and Induced Nontransgenic Animal Models of AD
Kaushal, A., Wani, W. Y., Anand, R., & Gill, K. D. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513488914 · Cited by 18
Patricio-Martínez, A., Mendieta, L., Martínez, I., Aguilera, J., & Limón, I. D. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.066 · Cited by 18
Khan, M. S., Althobaiti, M. S., Almutairi, G. S., Alokail, M. S., Altwaijry, N. A., Alenad, A. M. H., Al-Bagmi, M. S., & Alafaleq, N. O. (2022) · Biophysical Chemistry · doi:10.1016/j.bpc.2022.106823 · Cited by 18
Ali, M., Shamim, S., Salar, U., Taslımı, P., Saad, S. M., Taşkın‐Tok, T., Taha, M., & Khan, K. M. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.139863 · Cited by 17
The Potential Effects of Red Wine and Its Components on Neurocognitive Disorders: A Narrative Review
Boccardi, V., Tagliafico, L., Persia, A., Page, E., Ottaviani, S., Cremonini, A. L., Borgarelli, C., Pisciotta, L., Mecocci, P., Nencioni, A., et al. (2024) · Nutrients · doi:10.3390/nu16203431 · Cited by 18
Evaluation of the neuronal apoptotic pathways involved in cytoskeletal disruption-induced apoptosis
Jordà, E. G., Verdaguer, E., Jiménez, A., de Arriba, S. G., Allgaier, C., Pallàs, M., & Camins, A. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.036 · Cited by 17
Singh, D., Kapahi, H., Rashid, M., Prakash, A. K., Majeed, A. B. A., & Mishra, N. (2015) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2015.1029622 · Cited by 17
Porterfield, V. M., Khan, S. S., Foff, E. P., Köseoğlu, M. M., Blanco, I. K., Jayaraman, S., Lien, E. L., McConnell, M. J., Bloom, G. S., Lazo, J. S., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.02.011 · Cited by 18
Zhang, Q., Huang, Y., Hu, Y., Wei, G.-Z., Han, X., Lu, S.-Y., & Zhao, Y.-F. (2004) · PubMed · Cited by 17
Accelerated Alzheimer’s Aβ-42 secondary nucleation chronologically visualized on fibril surfaces
Nirmalraj, P. N., Bhattacharya, S., & Thompson, D. (2024) · Science Advances · doi:10.1126/sciadv.adp5059 · Cited by 16
Fanni, D., Gerosa, C., Rais, M., Ravarino, A., Eyken, P. V., Fanos, V., & Faa, G. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.063 · Cited by 17
Quantum capacitance-limited MoS 2 biosensors enable remote label-free enzyme measurements
Le, S. T., Guros, N. B., Bruce, R. C., Cardone, A., Amin, N. D., Zhang, S., Klauda, J. B., Pant, H. C., Richter, C. A., & Balijepalli, A. K. (2019) · Nanoscale · doi:10.1039/c9nr03171e · Cited by 16
González‐Domínguez, R., González‐Domínguez, Á., Sayago, A., Sanz, G., Lechuga-Sancho, A. M., & Fernández‐Recamales, Á. (2021) · Biomedicines · doi:10.3390/biomedicines9030298 · Cited by 18
Association studies of 22 candidate SNPs with late‐onset Alzheimer's disease
Figgins, J. A., Minster, R. L., Demirci, F. Y., DeKosky, S. T., & Kamboh, M. I. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30851 · Cited by 15
Zabłocka, A., Sokołowska, A., Macała, J., Bartoszewska, M., Mitkiewicz, M., Janusz, M., Wilusz, T., & Polanowski, A. (2019) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-019-09876-6 · Cited by 15
An Approach to the Patient with Cognitive Impairment: Delirium and Dementia
Caplan, J. P., & Rabinowitz, T. (2010) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.08.004 · Cited by 15
Epigenetic plasticity and redox regulation of neural stem cell state and fate
Tay, E. X. Y., Chia, K., & Ong, D. S. T. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.030 · Cited by 15
Zhang, Q., Liu, Y., Yang, N., Wan, X., & Zuo, P. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.040 · Cited by 15
Mellingen, R. M., Myrmel, L. S., Rasinger, J. D., Lie, K. K., Bernhard, A., Madsen, L., & Nøstbakken, O. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012242 · Cited by 14
Perdivara, I., Deterding, L. J., Cozma, C., Tomer, K. B., & Przybylski, M. (2009) · Glycobiology · doi:10.1093/glycob/cwp038 · Cited by 14
Henderson, L. E., Abdelmegeed, M. A., Yoo, S. H., Rhee, S. G., Zhu, X., Smith, M. A., Nguyen, R. Q., Perry, G. L., & Song, B. J. (2017) · The Open Neurology Journal · doi:10.2174/1874205x01711010048 · Cited by 14
Calvillo, M., Díaz, A., Limón, I. D., Mayoral, M. Á., Chánez‐Cárdenas, M. E., Zenteno, E., Montaño, L. F., Guevara, J., & Espinosa, B. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.06.002 · Cited by 14
Trifluoperazine protects brain plasma membrane Ca2+-ATPase from oxidative damaging
Santos, P. S., Saraiva, D. F., da Costa, D. C. F., Scofano, H. M., & Carvalho-Alves, P. C. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0678-1 · Cited by 14
Zamarbide, M., Martínez‐Pinilla, E., Gil-Bea, F. J., Yanagisawa, M., Franco, R., & Pérez‐Mediavilla, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073533 · Cited by 13
Yang, S., Sun, R.-C., Zhou, Z., Zhou, J., Liang, J., & Mu, H. (2014) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000000103 · Cited by 13
Potential role of inducible nitric oxide synthase in the sleep–wake states occurrence in old rats
Clément, P., Sarda, N., Cespuglio, R., & Gharib, A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.064 · Cited by 14
Vitamin E in disease prevention and therapy: future perspectives.
Packer, L., Obermüller-Jevic, U. C., Traber, M. G., Kraemer, K., & Frei, B. B. (2002) · Cited by 13
Espinosa-Jiménez, T., Cano, A. C., Sánchez‐López, E., Olloquequi, J., Folch, J., Bulló, M., Verdaguer, E., Auladell, C., Pont, C., Muñoz‐Torrero, D., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01000-y · Cited by 13
Silva, C. F. M., Guerrinha, A. P. D. D. M. S., Carvalho, S., Pinto, D. C. G. A., & Silva, A. M. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030882 · Cited by 12
Metadata
- Authors
- Maccioni, R. B., Muñoz, J. P., & Barbeito, L.
- Affiliations
- University of Chile (CL)
- Instituto de Investigaciones Biológicas Clemente Estable (UY)
- Corresponding author
- Maccioni, Ricardo B
- Venue
- Archives of Medical Research
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 32
- Issue
- 5
- Pages
- 367-381
- ISSN
- 0066-6769 (ISSN-L)
- 0188-4409
- OpenAlex
- W1985122965
- Cited by
- 474
- References
- 150
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 24 · 2023: 8 · 2022: 13 · 2021: 14 · 2020: 17 · 2019: 19 · 2018: 20 · 2017: 28 · 2016: 17 · 2015: 17 · 2014: 19 · 2013: 22 · 2012: 30
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- green
- americanae.aecid.es
- Licence
- Locations
- Archives of Medical Research (publishedVersion)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, neurodegeneration, amyloid plaques, neurofibrillary tangles, amyloid-beta, amyloid precursor protein, tau protein, tau hyperphosphorylation, cyclin-dependent kinase 5, GSK3β, oxidative stress, neuronal cell death, neuroprotective factors, estrogen, antioxidants, protein kinase inhibitors, antisense oligonucleotides, dementia
- MeSH terms
- Adult, Aged, alpha-Macroglobulins, Alzheimer Disease, Amino Acid Sequence, Apolipoproteins E, Astrocytes, Calcium, Estrogens, Humans, Membrane Proteins, Memory Disorders, Middle Aged, Molecular Sequence Data, Nerve Tissue Proteins, Neurons, Neurotoxins, Nitric Oxide, Parkinson Disease, Protein Processing, Post-Translational, Signal Transduction, Motor Neuron Disease, Amyloid beta-Protein Precursor, Neurofibrillary Tangles, tau Proteins, Cell Death, Age of Onset, Oxidative Stress, Neurodegenerative Diseases, Caspases, Presenilin-1, Presenilin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
